BioSpace News Archive

The global atherosclerosis drugs market size reached USD 48.40 Billion in 2021 and is expected to register a revenue CAGR of 2.5% during the forecast period, according to latest analysis by Emergen Research.

The latest market analysis report published by Reports and Data, titled ‘Global Deep Vein Thrombosis (DVT)t Market – Forecast to 2030,’ thoroughly examines the Deep Vein Thrombosis (DVT)t industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Oligonucleotidet Market – Forecast to 2030,’ thoroughly examines the Oligonucleotidet industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Synovial Sarcoma Treatment Market – Forecast to 2030,’ thoroughly examines the Synovial Sarcoma Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global WHIM Syndrome Treatment Market – Forecast to 2030,’ thoroughly examines the WHIM Syndrome Treatment industry to provide essential data & information for the targeted readers.

The Amyloidosis Research Consortium announces the launch of ASPIRE: Amyloidosis Stakeholder Partnerships for Impact Reach and Equity, a collaborative of biotech and pharmaceutical companies committed to advancing solutions, improving diagnosis and systems of care, and addressing obstacles to health equity on behalf of amyloidosis patients.

Paradigm Biopharmaceuticals Ltd is pleased to announce that the primary endpoint has been met and additionally significant improvement in Western Ontario and McMaster Universities Osteoarthritis Index pain and function scores were demonstrated for injectable iPPS in the PARA_OA_008 phase 2 clinical trial.

The forensic genomics market is anticipated to witness significant growth as the majority of companies aim to use customer databases in combination with cutting-edge sequencing technologies.

According to Vision Research Reports, the global gene panel market was surpassed at USD 750.8 million in 2021 and is expected to hit around USD 2.97 billion by 2030, growing at a CAGR of 16.51% from 2022 to 2030.

Starlight Cardiovascular announced that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress development of its portfolio of pediatric interventional cardiology devices.